Cancer Testing | Clearbridge Medical
Clearbridge Medical

Cancer Testing

🔬 FDA-Approved

Actionable gold-standard liquid biopsy analysis.

🧬 139 Genes

Comprehensive hereditary cancer genetic profiling.

📊 Risk Assessment

Early-stage detection aiding key therapy decisions.

🌐 Accredited Labs

Processed by elite clinical molecular networks.

The Value of Knowing For Sure

The genes we are born with could be a factor in contributing to our risk of developing certain types of cancer. If there is a history of cancer in your family, Clearbridge Medical endeavors to guide you in understanding your risk for disease. We offer cancer screening and testing and can assist you in making informed medical decisions.

Cell Search CTC Microscope Close-up

Cell Search® CTC Test

Exclusively performed by SAM Clinical Laboratory in Southeast Asia, the Cellsearch® (CTC) Test is the only FDA-approved test for enumerating CTCs. It is an actionable test that assists healthcare professionals in the assessment of patients with metastatic breast, prostate or colorectal cancer.

Learn More

Hereditary Cancer Test

The test is a cancer diagnostic tool that gives a comprehensive analysis of 139 genes associated with the most common hereditary cancers: brain, breast, colorectal, kidney, leukemia, liver, lung, melanoma, pancreatic, prostate, ovarian, stomach, thyroid and uterine.

Learn More
Happy multi-generational family
Breast cancer pink ribbon background

Prosigna

Now included in the International Clinical Practice Guidelines, Prosigna by Nanostring detects early stage breast cancer in patients through a highly accurate, FDA-approved risk assessment test.

Learn More

Take Control of Your Health

Get in touch with our clinical experts to schedule an assessment or discuss genetic screening options.

BOOK A CONSULTATION
CBMG Footer